Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537716 | Vaccine | 2016 | 6 Pages |
Abstract
IVAC's seasonal, trivalent influenza vaccine was safe and well tolerated and induced high levels of seroconversion and seroprotection rates. These clinical data are a first step towards demonstrating the feasibility of producing the vaccine locally and that seasonal vaccine production in Vietnam may be an effective strategy for enhancing the global influenza vaccine supply. ClinicalTrials.gov number NCT02598089, October 15, 2015.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Dang Duc Anh, Vu Dinh Thiem, Nguyen Thi Hien Anh, Vu Minh Huong, Nguyen Tuyet Nga, Tran Cong Thang, Duong Huu Thai, Vien Chinh Chien, Renee Holt, Rahnuma Wahid, Jorge Flores, Francesco Berlanda Scorza, David N. Taylor,